Online Attendance

TCTAP 2026 provides complimentary live streaming access to selected sessions from the Main Arena and Presentation Theater 1, April 30-May 1, 2026.
ONLINE ATTENDANCE
  • All registered participants (On-site and Online) may access the livestream using their registered TCTAP 2026 account.
  • Online-only attendance is not eligible for the certificate of attendance.
Live Streaming Sessions

Thursday, April 30

Main Arena, Level 1

10:10 AM | Live Case
Live Case 1: Left Main

Live Case

Live Case 1: Left Main

Thursday, April 30
10:10 AM ~ 11:10 AM * KST (UTC/GMT +9:00)
Main Arena, Level 1
10:10 AM Asan Medical Center, Korea: Case #1
1st Operator: Jung-Min Ahn
10:40 AM Asan Medical Center, Korea: Case #2
1st Operator: Do-Yoon Kang
11:10 AM | Main Arena
Opening of TCTAP 2026

Main Arena

Opening of TCTAP 2026

Thursday, April 30
11:10 AM ~ 11:25 AM * KST (UTC/GMT +9:00)
Main Arena, Level 1
11:10 AM Welcome Remark
11:15 AM Congratulatory Remark
Speaker: Seok-Min Kang
11:20 AM Brief Overview of TCTAP 2026 Program Highlights
Speaker: Duk-Woo Park
11:25 AM | Main Arena
16th TCTAP Master of the Masters Award

Main Arena

16th TCTAP Master of the Masters Award

Thursday, April 30
11:25 AM ~ 11:55 AM * KST (UTC/GMT +9:00)
Main Arena, Level 1
11:25 AM Award Presentation
11:40 AM Special Lecture by the Award Recipient
1:30 PM | Live Case
Live Case & Lecture 2: Complex TAVR

Live Case

Live Case & Lecture 2: Complex TAVR

Thursday, April 30
1:30 PM ~ 2:47 PM * KST (UTC/GMT +9:00)
Main Arena, Level 1
1:30 PM Asan Medical Center, Korea: Case #3
1st Operator: Duk-Woo Park
2:00 PM Asan Medical Center, Korea: Case #4
Operator(s): Jung-Min Ahn, Ho Jin Kim
2:30 PM [Featured Lecture] Contemporary TAVR: Best Practices and the Road Ahead
Lecturer: Eberhard Grube
2:42 PM Discussion
2:50 PM | TCTAP Workshops
Left Main & Multi-Vessel Disease: Modern Evidence and Real-World Strategy

TCTAP Workshops

Left Main & Multi-Vessel Disease: Modern Evidence and Real-World Strategy

Thursday, April 30
2:50 PM ~ 4:25 PM * KST (UTC/GMT +9:00)
Main Arena, Level 1
2:50 PM PCI vs. CABG in Left Main and Multi-Vessel Disease: Evidence, Controversies, and Clinical Decision-Making
2:58 PM PCI vs. CABG in Diabetic Patients With Multi-Vessel Disease: Why We Need Novel RCT?
Lecturer: Duk-Woo Park
3:06 PM Long-Term Data on PCI vs. CABG for Multi-Vessel Disease: Lessons From FAME-3 Trial and Futuer Perspective
3:14 PM Long-Term Data on PCI vs. CABG for Left Main Disease: Lessons From NOBLE and Other RCT and Futuer Perspective
3:22 PM Panel Discussion I
3:37 PM RECHARGE: A Novel Ongoing Trial of PCI vs. CABG in Women
Lecturer: Gregg W. Stone
3:45 PM State-of-the-Art CABG in 2026: Preserving the Gold Standard in Coronary Revascularization
3:53 PM OPTIMAL: IVUS- Versus Angiography-Guided Unprotected Left Main PCI
4:01 PM Optimal Treatment Strategy for LM ISR: DES, DCB, or CABG?
Lecturer: Do-Yoon Kang
4:09 PM Panel Discussion II
4:30 PM | Live Case
Live Case 3: CTO

Live Case

Live Case 3: CTO

Thursday, April 30
4:30 PM ~ 5:30 PM * KST (UTC/GMT +9:00)
Main Arena, Level 1
4:30 PM Severance Hospital, Korea: Case #5
1st Operator: Byeong-Keuk Kim
5:00 PM Toyohashi Heart Center, Japan: Case #6
1st Operator: Maoto Habara

Presentation Theater 1, Level 1

8:30 AM | TCTAP Workshops
When to Consider CTO PCI: From Decision to Execution

TCTAP Workshops

When to Consider CTO PCI: From Decision to Execution

Thursday, April 30
8:30 AM ~ 9:50 AM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1

Concept of CTO PCI

8:30 AM CTO PCI: When Is It Truly Indicated?: A Guideline-Based Perspective
Lecturer: Jung-Min Ahn
8:38 AM OMT vs. PCI for Single-Vessel CTO: A Combined Analysis From DECISION-CTO and EUROCTO Trials
Lecturer: Gerald Werner
8:46 AM Panel Discussion I

Strategy for Successful CTO PCI

8:56 AM CT Planning for Successful CTO PCI
Lecturer: Scott Harding
9:04 AM How to Perform CTO Safely and Manage Complication
Lecturer: Shozo Ishihara
9:12 AM How to Master Wire Escalation in CTO PCI: Tips, Tools, and Techniques
Lecturer: Kenya Nasu
9:20 AM Conventional CTO-PCI vs. Hybrid CTO-PCI: Which One Should I Follow?
9:28 AM Navigating the CTO Crossing Algorithm: The 2026 APCTO Perspective
Lecturer: Eugene Brian Wu
9:36 AM Panel Discussion II
3:00 PM | Hot Topics
Interventional Heart Failure Treatment

Hot Topics

Interventional Heart Failure Treatment

Thursday, April 30
3:00 PM ~ 4:20 PM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1
3:00 PM Treatment of Heart Failure With Pulmonary Artery Denervation: PULSE-LHD
Lecturer: Gregg W. Stone
3:08 PM Interatrial Shut in Heart Failure: Does It Work and If Yes, in Which Cases
Lecturer: Teguh Santoso
3:16 PM Various Hemodynamic Monitoring With PAC in CS
Lecturer: Min Seok Kim
3:24 PM Endovascular Baroreflex Amplification in Heart Failure With Reduced Ejection Fraction
Lecturer: Horst Sievert
3:32 PM Panel Discussion I
3:46 PM Role of ECMO in Fulminant Myocarditis: Korean Multicenter Registry
Lecturer: Junho Hyun
3:54 PM Mechanical Circulatory Support in AMI and Cardiogenic Shock
Lecturer: Junya Ako
4:02 PM Cardiogenic Shock in Women, Is It Different?
4:10 PM Panel Discussion II
4:20 PM | TCTAP Workshops
Mitral and Tricuspid Intervention: Practical Strategies and Techniques

TCTAP Workshops

Mitral and Tricuspid Intervention: Practical Strategies and Techniques

Thursday, April 30
4:20 PM ~ 5:40 PM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1
4:20 PM Transcatheter Mitral Valve Therapy: Beyond Surgical Predicate
Lecturer: Eberhard Grube
4:28 PM Transcatheter Repair Versus Replacement for Mitral Valve Insufficiency
4:36 PM TMVR vs. Redo-Surgical MVR for Mitral Bioprosthetic Valve Dysfunction
Lecturer: James Flaherty
4:44 PM Predicting and Preventing LVOT Obstruction During TMVR
Lecturer: David J. Cohen
4:52 PM Panel Discussion I
5:07 PM Electrosurgery for Mitral Valve Intervention: When and How to Use It
5:15 PM T-TEER: Technical and Procedural Best Practices
Lecturer: Khung Keong Yeo
5:23 PM Update on Tricuspid Valve Repair and Replacement Techniques
Lecturer: Horst Sievert
5:31 PM Panel Discussion II

Friday, May 1

Presentation Theater 1, Level 1

8:30 AM | Clinical Science
Late-Breaking Clinical Trials 2026

Clinical Science

Late-Breaking Clinical Trials 2026

Friday, May 1
8:30 AM ~ 10:05 AM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1
8:30 AM PARTNER 3: 7-Year Clinical and Echocardiographic Outcomes of TAVR vs. SAVR
8:38 AM Early Surgery Versus Conservative Management for Asymptomatic Severe Aortic Stenosis: Final Outcomes of the RECOVERY Trial
Lecturer: Duk Hyun Kang
8:46 AM A Large-Scale, Global Randomized Trial of Coronary Physiology Derived From Conventional Angiography Compared With an Invasive Pressure Wire-Based Approach to Guide Percutaneous Coronary Intervention
8:54 AM Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/​dL; Ez-PAVE Trial
Lecturer: Byeong-Keuk Kim
9:02 AM Panel Discussion I
9:17 AM Appropriate Duration of Antiplatelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug-Eluting Stents : ADAPT AF-DES Trial
Lecturer: Jung-Sun Kim
9:25 AM Temporal Modulation of Antiplatelet Therapy in High-Risk Patients Undergoing Complex Percutaneous Coronary Intervention: TAILORED-CHIP Trial
Lecturer: Hanbit Park
9:33 AM Ticagrelor Versus Prasugrel in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Data From TUXEDO-2 Trial
9:41 AM Optimal Timing of FFR-Guided Complete Revascularization for Non-Infarct-Related Artery in STEMI With Multivessel Disease : OPTION–STEMI Trial
Lecturer: Youngkeun Ahn
9:49 AM Panel Discussion II
10:05 AM | Clinical Science
All About New Data From Asan Medical Center

Clinical Science

All About New Data From Asan Medical Center

Friday, May 1
10:05 AM ~ 11:00 AM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1
10:05 AM Clinical Effect of Cerebral Embolic Protection Device Following Transcatheter Aortic-Valve Replacement in Korea
Lecturer: Hansu Park
10:13 AM The Implication of Early Bleeding on Subsequent Clinical Outcomes in Patients With Coronary Artery Disease and Atrial Fibrillation
Lecturer: Soo Yeon An
10:21 AM TAILORED-CHIP Trial: Ischemic and Bleeding Risks After Complex PCI
Lecturer: Seongbong Wee
10:29 AM Antithrombotic Therapy in Diabetic Patients With Atrial Fibrillation and Stable Coronary Artery Disease
Lecturer: Seung-Han Lee
10:37 AM OCT- or IVUS-Guided Percutaneous Coronary Intervention for In-Stent Restenosis Lesions
Lecturer: Kyeong Won Seo
10:40 AM Panel Discussion
11:00 AM | Clinical Science
Ongoing and Future RCTs From Asan Medical Center

Clinical Science

Ongoing and Future RCTs From Asan Medical Center

Friday, May 1
11:00 AM ~ 12:10 PM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1
11:00 AM DEFINE-DM Trial: Imaging- and Physiology-Guided State-of-the Art PCI vs. CABG for DM and Multi-Vessel Disease
Lecturer: Seongbong Wee
11:06 AM FATE-MAIN Trial: FFR- vs. Angiography-Guided Left Main PCI
Lecturer: Ju Hyeon Kim
11:12 AM ASA-3C Trial: AcetylSalicylic Acid Use for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Lecturer: Hoyun Kim
11:18 AM Panel Discussion I
11:30 AM PROTECT-HBR Trial: New GI Protection Drug for High-Bleeding Risk Patients Requiring Antithrombotic Agents: P-CAB vs. PPI
Lecturer: Hanbit Park
11:36 AM PREVENT Trials: PCI for Vulnerable Plaque From PREVENT I to PREVENT II
Lecturer: Jung-Min Ahn
11:42 AM RENOVATE Trial: DOAC vs. Warfarin for Mechanical Aortic Valve Prosthesis
Lecturer: Hong Rae Kim
11:48 AM ENAVO-TAVR Trial: SGLT-2 Inhibitor for Post-TAVR Patients
Lecturer: Soo Yeon An
11:54 AM Panel Discussion II
1:30 PM | Hot Topics
Advances in Coronary Imaging

Hot Topics

Advances in Coronary Imaging

Friday, May 1
1:30 PM ~ 2:55 PM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1
1:30 PM OCT-Guided Complex PCI: Insights From OCCUPI Trial
Lecturer: Byeong-Keuk Kim
1:38 PM OCT vs. IVUS for Guiding PCI : Data From OCTIVUS Substudies
Lecturer: Ju Hyeon Kim
1:46 PM Intracoronary Imaging for PCI: Should Everyone Get It or Only Selected Patients?
Lecturer: Takashi Kubo
1:54 PM Panel Discussion I
2:09 PM Building an Intracoronary Imaging Program: From Start to Success
Lecturer: Eveline Regar
2:17 PM Imaging-Guided PCI in Calcified Lesions: Tips, Tricks, and Success
Lecturer: Doosup Shin
2:25 PM Beyond Angiography: CT-Derived Virtual Stenting for Revascularization Optimization (CT-COMPASS Trial)
Lecturer: Kefei Dou
2:33 PM Identifying Culprit and Non-Culprit High-Risk Plaques With Multimodality Imaging
Lecturer: Bon-Kwon Koo
2:41 PM Panel Discussion II
2:55 PM | Hot Topics
Advances in Coronary Physiology

Hot Topics

Advances in Coronary Physiology

Friday, May 1
2:55 PM ~ 4:20 PM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1
2:55 PM Scenario-Specific, Evidence-Based Invasive Coronary Physiology in the Cath Lab
3:03 PM Prognostic Value of FFR-NHPR Discordance and Revascularization: J-Pride Registry
3:11 PM Microvascular Function Test in Daily Practice
Lecturer: Joo Myung Lee
3:19 PM Panel Discussion I
3:24 PM My Case for Wire-Based Physiology and Wireless Physiology
Lecturer: Doyeon Hwang
3:42 PM ALL-RISE Randomized Clinical Trial: Resolving Issue of Angio Based FFR in Clinical Practice
3:50 PM Can Imaging-Derived Physiology Change PCI Outcomes? Insights From China
Lecturer: Lei Song
3:58 PM FFR CT in Practice: Accuracy Across Diverse Subgroups
Lecturer: Jung-Min Ahn
4:06 PM Panel Discussion II
4:20 PM | Hot Topics
Emerging Trends in Mitral and Tricuspid Valve Therapy

Hot Topics

Emerging Trends in Mitral and Tricuspid Valve Therapy

Friday, May 1
4:20 PM ~ 5:50 PM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1
4:20 PM Treatment of Moderate Mitral Regurgitation With TEER
Lecturer: Gregg W. Stone
4:28 PM What Are We Learning From the OCEAN-Mitral Registry?
Lecturer: Shunsuke Kubo
4:36 PM TEER in Real-World Canadian Practice: Data From PREMISE Study
Lecturer: Shamir R. Mehta
4:44 PM TEER in Atrial Functional MR: Evidence and Real-World Practice
Lecturer: Jung-Sun Kim
4:52 PM Catheter Anuloplasty With the Carillon Device
Lecturer: Horst Sievert
5:00 PM Panel Discussion I
5:15 PM Quality of Life After Transcatheter Tricuspid Valve Interventions: Real, Meaningful, and Enough?
Lecturer: David J. Cohen
5:23 PM The CIED Dilemma in TR: A Practical Guide to T-TEER, TTVR, or Surgery
5:31 PM Current Status and Recent Updates in Transcatheter Tricuspid Therapies in Asia-Pacific
Lecturer: Shih-Hsien Sung
5:39 PM Panel Discussion II
If you have any questions about conference or registration, please check FAQ first and contact us.